SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Clinical trial NCT04972721 · COMPLETED
Trial details
- NCT number
- NCT04972721
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-08-25
- Enrollment
- 3439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.